A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.

This was the stock's second consecutive day of gains.

At the crossroads of innovation and equity, Josette Gbemudu and Merck are helping rewrite the narrative for breast cancer ...